Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Juan Carlos Cejudo"'
Publikováno v:
Neurology International, Vol 16, Iss 4, Pp 853-868 (2024)
Objective: To evaluate and characterize the cognitive changes in COVID-19 participants at 6-month follow-up, and to explore a possible association with clinical symptoms, emotional disturbance and disease severity. Methods: This single-center longitu
Externí odkaz:
https://doaj.org/article/56a286c7753343a9be4ce2cc625f3ce5
Publikováno v:
Brain Sciences, Vol 14, Iss 6, p 604 (2024)
Objective: To characterize the cognitive profile of long COVID-19 subjects and its possible association with clinical symptoms, emotional disturbance, biomarkers, and disease severity. Methods: We performed a single-center cross-sectional cohort stud
Externí odkaz:
https://doaj.org/article/e03b50ab4d7d48abb10b4b29ad3c2f2f
Publikováno v:
Brain and Behavior, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Objective: To characterize the cognitive profile following COVID‐19 infection and its possible association to clinical symptoms, emotional disturbance, biomarkers, and disease severity. Methods: This was a single‐center cross‐sectional
Externí odkaz:
https://doaj.org/article/d9c7ad6bbf2e4701ac7ecc531be97d1b
Autor:
Juan Carlos, Cejudo, Melissa, Samaniego, Marta, Almeria, Susana, Castrillo, Lidia, Medina, Domènec, Gil
Publikováno v:
Journal of Alzheimer's Disease. 90:151-160
Background: Semantic memory (SM) constitutes a cognitive system that is seriously affected by Alzheimer’s disease (AD). There are several tests for assessing SM, but a tool is needed to assess AD in the early stages of the illness. Objective: The s
Autor:
Daniela Torrealba‐García, Pilar Garcia‐Morales, Eduardo Torrealba, Juan Carlos Cejudo, Javier Silvestre‐Rangil
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Eduardo Torrealba, Aurelio Rodriguez-Perez, Francisco Rodríguez-Esparragón, Juan Carlos Cejudo, Florentino Sanchez-Garcia, Mario Díaz, Pilar Garcia-Morales, Raquel Marin, Nina Gramunt, Fátima Mesa-Herrera, Oscar Fabre
Publikováno v:
Journal of Alzheimer's Disease
Background: Assessment of hippocampal amnesia is helpful to distinguish between normal cognition and mild cognitive impairment (MCI), but not for identifying converters to dementia. Here biomarkers are useful but novel neuropsychological approaches a
Publikováno v:
Brain, Behavior, & Immunity-Health, Vol 9, Iss, Pp 100163-(2020)
Brain, Behavior, & Immunity-Health
Brain, Behavior, & Immunity-Health
Background Cognitive manifestations associated with the severity of a novel coronavirus (COVID-19) infection are unknown. An early detection of neuropsychological manifestations could modify the risk of subsequent irreversible impairment and further
Publikováno v:
Journal of Alzheimer's Disease. 53:705-712
BACKGROUND It has been suggested that mild cognitive impairment (MCI) can be used to identify patients at risk of developing clinical stages of Alzheimer's disease (AD). OBJECTIVE The aim of this study was to describe the characteristics of amnesic s
Autor:
Noemi Calzado, Laura Casas, Dolors Badenes, S. Zaragoza, Maite Garolera, Juan Carlos Cejudo-Bolivar, Miquel Aguilar
Objective: To determine whether the standard Spanish driving test (ASDE test) was able to identify patients with Parkinson's disease (PD) at risk of unsafe driving and to examine the relationship between the ASDE test and the Useful Field of View (UF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbc9a32a2e30c02b1b27a159e287b63